Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.064 AUD | +3.23% | -1.54% | +190.91% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+190.91% | 7.39M | |
+37.74% | 723B | |
+32.22% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.60% | 244B | |
+9.77% | 208B | |
-5.15% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Validates Effectivity of Inhibitor Drug to Block Early Atherosclerosis; Shares Fall 6%